drugset / Trial / NCT02721940
Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis
RandomizedParallel-groupSingle-blindTreatment
Summary
This study was mainly aimed to evaluate the efficacy of local administration of enriched bone marrow mononuclear cells, platelets and zoledronic acid for the clinical prevention of collapse of the early-stage osteonecrotic femoral head.
Timeline
- Start
- 2012-02
- Primary completion
- 2015-01
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mononuclear cells | Cell therapy | — | Other |
| Subject | Platelets | Other / unclassified | — | Other |
| Subject | Zoledronic acid | Other / unclassified | 200 ug | Other |